ArticleBriefings in bioinformatics2026
DeepU-PRS: nonlinear and uncertainty-aware SNP heritability modeling for annotation-informed polygenic risk scoring.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Polygenic risk scores (PRSs) are widely used to quantify genetic predisposition to complex traits, and their predictive accuracy can be enhanced by incorporating functional annotations into single-nucleotide polymorphism (SNP) effect-size estimation. Existing approaches typically assume linear relationships between annotations and SNP effects, neglecting predictive aleatoric variance and potential nonlinear regulatory interactions. To evaluate the gains of nonlinear and uncertainty-aware modeling, we developed DeepU-PRS, a deep ensemble framework that extends the linear BLD-LDAK model with a neural network trained on functional annotations to jointly estimate SNP heritability and its aleatoric uncertainty, which are then integrated into a Bayesian PRS model. Across 28 continuous and 8 disease phenotypes in the UK Biobank, DeepU-PRS improved the mean continuous R2 by approximately 10% over linear BLD-LDAK, with the largest gains for traits whose association signals were concentrated, whereas the more diffuse disease traits favored BLD-LDAK. These patterns were reproduced in individual-level data from All of Us. Against a panel of established methods (C + T, Lassosum, PRS-CS, LDpred-funct, and SBayesRC), DeepU-PRS was among the strongest single methods on continuous traits, and ensembles combining DeepU-PRS with the linear baseline and SBayesRC further improved accuracy, indicating complementary predictive signal. These findings highlight the value of modeling nonlinear and uncertain regulatory effects to advance PRS prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.